Consumer Health in the United Kingdom
Euromonitor International
October 2020

List OF CONTENTS AND TABLES

EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 2 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2015-2020
Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
Table 8 Distribution of Consumer Health by Format: % Value 2015-2020
Table 9 Distribution of Consumer Health by Format and Category: % Value 2020
Table 10 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
KEY DATA FINDINGS
2020 IMPACT
Pandemic generates exponential demand for acetaminophen and leads to shortages within the global supply chain
Despite French Authorities warning against using ibuprofen to treat COVID-19 symptoms, adult ibuprofen remains the most sought-after systematic analgesic with high yearly sales overall
Reckitt Benckiser to retain lead, but faces challenges from GlaxoSmithKline's 2019 joint venture with Pfizer
RECOVERY AND OPPORTUNITIES
Heightened sensitivity amongst local consumers linked to threat level of virus will support demand for analgesics into 2021 before return to normalisation
Topical analgesics/anaesthetic predicted to see stable performance over the forecast period, influenced by demographics and changing routines
Distribution channel shifts and the likely ongoing rise of e-commerce
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2015-2020
Table 13 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 14 NBO Company Shares of Analgesics: % Value 2016-2020
Table 15 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 16 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Younger customers gravitate towards natural remedies and experiential medicine formats until COVID-19 fears drive more standard purchases
Preventive health has a new definition following emergence of COVID-19, supporting vitamins and supplements through “just in case” purchases
Advertising and combination products hold the key to success in 2020
RECOVERY AND OPPORTUNITIES
Seasonal demand and possible second wave of COVID-19 in autumn/winter could support sales in late 2020 but growth set to return to normalisation from 2021/2022
Antihistamines and decongestants set to continue to experience growth, addressing both allergies and additional illnesses
Strong growth of paediatric cough/cold remedies during 2020 set to wane despite expansion of category
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Ranitidine recalls wipe out H2 blockers for foreseeable future, potentially permanently
Probiotics and healthy lifestyles continue to impact digestive remedies, despite peaks in early 2020 due to panic buying following emergence of COVID-19
A product for all occasions: Gaviscon, Guardium and Rennie appeal to the masses
RECOVERY AND OPPORTUNITIES
Waning interest in digestive remedies predicted for forecast period as consumers increasingly look to health and wellness trends in an effort to take a more preventive approach
Despite ongoing declines, motion sickness remedies could be worth the long-term investment
Future of laxatives remains gloomy following MHRA review and greater efforts by consumers to improve diet and exercise
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2015-2020
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
Table 26 NBO Company Shares of Digestive Remedies: % Value 2016-2020
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Early stockpiling and precautionary measures against COVID-19 improve overall performance of dermatologicals
Antifungals and antipruritics benefit from COVID-19-related lifestyle changes
Intense competition amongst leading players but a leaning towards more natural products benefits smaller brands within paediatric segment
RECOVERY AND OPPORTUNITIES
Future growth is expected from paediatric dermatologicals, haemorrhoid treatments and antiparasitics/lice treatments
Warmer weather in the UK could continue to influence positive demand for a number of dermatologicals over the forecast period
Distribution channels shifts could lead to further share gain for e-commerce
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2015-2020
Table 31 Sales of Dermatologicals by Category: % Value Growth 2015-2020
Table 32 NBO Company Shares of Dermatologicals: % Value 2016-2020
Table 33 LBN Brand Shares of Dermatologicals: % Value 2017-2020
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
Table 35 Forecast Sales of Dermatologicals by Category: Value 2020-2025
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Continuous decline in the number of smokers, exacerbated by concerns over respiratory health relating to COVID-19, supports greater demand for NRT
The EVALI scandal impacting e-vapour products at end of 2019 might boost NRT sales
Nicorette, Nicotinell and NiQüitin maintain their hold over NRT smoking cessation aids
RECOVERY AND OPPORTUNITIES
Weaker performance predicted for NRT smoking cessation aids due to shrinking consumer base
Incorporating technology within NRT might be the new way forward
Opportunity to target smokers with combined NRT solutions
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2015-2020
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2016-2020
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2017-2020
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Insomnia rates on the rise pre-COVID-19 lead to increasing interest in sleep aids
Sleeping challenges exacerbated by pandemic increase interest in alternative health remedies
Omega Pharma Ltd leads with a solid Nytol range
RECOVERY AND OPPORTUNITIES
Ongoing stressful lifestyles and demographic changes likely to support demand for sleep aids beyond pandemic
Sleeps aids to benefit from increasing proof between a good night's sleep and reduced health issues
Consumers are increasingly aware of alternative sleep aids
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2015-2020
Table 45 Sales of Sleep Aids: % Value Growth 2015-2020
Table 46 NBO Company Shares of Sleep Aids: % Value 2016-2020
Table 47 LBN Brand Shares of Sleep Aids: % Value 2017-2020
Table 48 Forecast Sales of Sleep Aids: Value 2020-2025
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Increased screen time during pandemic results in increasing sales of eye drops
Early incidence of hay fever in 2020 supports allergy eye care sales
Reckitt Benckiser set to strengthen convincing leadership in 2020 due to wide ranging portfolio but Boots private label line attracts increasingly price-sensitive consumers
RECOVERY AND OPPORTUNITIES
Lifestyle changes set to continue to support demand for eye care beyond pandemic
Increased levels of stress also believed to impact eye health
Ageing population will continue to help drive sales of standard eye care
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2015-2020
Table 51 Sales of Eye Care by Category: % Value Growth 2015-2020
Table 52 NBO Company Shares of Eye Care: % Value 2016-2020
Table 53 LBN Brand Shares of Eye Care: % Value 2017-2020
Table 54 Forecast Sales of Eye Care by Category: Value 2020-2025
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
COVID-19 and subsequent lockdown measures pose threat to first aid kits
New lifestyles under COVID-19 lead to demand for certain wound care products
Convenience and price sensitivity supports strengthening sales of private label within wound care
RECOVERY AND OPPORTUNITIES
Demographics likely to maintain fairly steady demand for wound care
Tesco paves the way for inclusive sticking plasters and encourages competitors to follow suit
Healthier lifestyles and desire to venture outside of the home likely to support demand for wound care going forward
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2015-2020
Table 57 Sales of Wound Care by Category: % Value Growth 2015-2020
Table 58 NBO Company Shares of Wound Care: % Value 2016-2020
Table 59 LBN Brand Shares of Wound Care: % Value 2017-2020
Table 60 Forecast Sales of Wound Care by Category: Value 2020-2025
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Emergence of COVID-19 supports preventive health trend due to greater demand for immune-boosting vitamins
Sales of vitamins via e-commerce accelerate during lockdown
Product shortages increase alongside a hike in pricing
RECOVERY AND OPPORTUNITIES
Proof of efficacy key to growth
Pill fatigue to give rise to new formats
Economic factors limit spending
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2015-2020
Table 63 Sales of Vitamins by Category: % Value Growth 2015-2020
Table 64 Sales of Multivitamins by Positioning: % Value 2015-2020
Table 65 NBO Company Shares of Vitamins: % Value 2016-2020
Table 66 LBN Brand Shares of Vitamins: % Value 2017-2020
Table 67 Forecast Sales of Vitamins by Category: Value 2020-2025
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Immunity-positioned products drive growth in 2020
CBD's strong growth begins to slow
Holland & Barrett's launch meets variety of consumers' needs in 2020
RECOVERY AND OPPORTUNITIES
Mental wellness gives opportunity to dietary supplements moving forward
Multiple benefits of probiotics to support growth
Vitabiotics' portfolio and efficacy focus are key to future growth
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2015-2020
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
Table 71 Sales of Dietary Supplements by Positioning: % Value 2015-2020
Table 72 NBO Company Shares of Dietary Supplements: % Value 2016-2020
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
OTC obesity and weight loss supplements to continue losing share
Health specialists urge public to take nutrient-dense products to fight the virus
Meal replacement driven by Huel, resulting in overall change in leadership for weight management and wellbeing in 2020
RECOVERY AND OPPORTUNITIES
Weight gain during lockdown likely to support stronger demand for weight management in early part of forecast period
Gradual return to busier lifestyles to support demand for convenient meal replacement shakes
E-commerce likely to continue gaining value share within weight management and wellbeing
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Gym closures impact demand for sports nutrition
Convenience products impacted differently
Dynamic performances by protein/energy bar brands in 2020
RECOVERY AND OPPORTUNITIES
Prioritisation of health and mental wellbeing to drive future growth
Opportunity in immunity and nootropics
Personalisation within sports nutrition may prove too costly in short term for increasingly price-sensitive consumers
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2015-2020
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
Table 84 NBO Company Shares of Sports Nutrition: % Value 2016-2020
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
CBD emerges as key alternative to herbal remedies' success, quelling sleep and anxiety needs during and post lockdown, although future growth remains uncertain
Growth of herbal/traditional cough, cold and allergy (hay fever) remedies slows in comparison to standard products during lockdown
Highly fragmented competitive environment with brands addressing rising stress and anxiety levels performing well
RECOVERY AND OPPORTUNITIES
Healthy performance predicted for herbal/traditional products over the forecast period
Stronger demand for herbal/traditional paediatric dietary supplements to continue throughout 2020 before giving way to slower growth
Herbal/traditional tonics will continue to benefit from preventive approach to ageing and immunity
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2015-2020
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Pandemic consolidates parents spending a premium on their children's health
With COVID-19 and lockdown hampering travel, motion sickness remedies is worst affected category
Paediatric consumer health remains dominated by large players but brands with natural positioning predicted to fare well in 2020
RECOVERY AND OPPORTUNITIES
Paediatric consumer health set to witness stable growth over early part of forecast period, considering parental preventive measures
Herbal/traditional set to outperform standard paediatric vitamins and dietary supplements as parents look for more natural solutions
Paediatric dermatologicals will continue to see growth, albeit at slower pace
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2015-2020
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025